Studies find that patients are amenable but that medical staffs often don't have time to carry it out, and links to care can be awkward.

With more diabetes patients living longer, a greater number need more intensive glucose-controlling regimens and help with managing complications.

Measure also provides the Food and Drug Administration with the clout to require postmarketing studies and label changes.

Lives could be saved and health care costs trimmed if disease prevention becomes a focus, according to a new coalition.

But a tool used to assess this finding may not be accurate for this purpose, and other system factors could be more important.